BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  RxBenefit Clarity™ Delivers Prescription Price Transparency to Providers on athenahealth’s Cloud-based EHR

  Patients can now review reliable prescription cost and coverage information prior to pharmacy visits

  October 23, 2018

   · 

  4 min read
• Business

  Quest Diagnostics Reports Third Quarter 2018 Financial Results

  Third quarter revenues of $1.89 billion, up 1.8% from 2017

  October 23, 2018

   · 

  19 min read
• Biotech Bay

  Synthego Receives $110M in Funding to Accelerate Global Access to Genome Engineering

  Series C investment expedites Synthego’s CRISPR product expansion to facilitate industry development of new therapies, adds cell therapy pioneer Dr. Matthew Porteus to advisory board

  October 23, 2018

   · 

  4 min read
• Drug Development

  KN035, a Global Leading Subcutaneously-administered PD-L1 Antibody, Starts Late-stage Clinical Development

  KN035’s US Phase I clinical data was presented at the annual ESMO Congress

  October 23, 2018

   · 

  3 min read
• Business

  Senti Biosciences Announces Dr. Gary Lee as Chief Scientific Officer

  Synthetic biology company taps veteran biotech executive to drive next-generation cell and gene therapy programs into the clinic

  October 23, 2018

   · 

  3 min read
• Deals

  CASI Pharmaceuticals Acquires HBV ANDA from Laurus Labs Limited

  The drug, tenofovir disoproxil fumarate (TDF), is indicated for the treatment of hepatitis B virus (HBV).

  October 23, 2018

   · 

  6 min read
• Business

  Acceleron to Webcast Third Quarter 2018 Operating and Financial Results on October 30, 2018

  The webcast will be accessible under “Events & Presentations” in the Investors/Media page of the company’s website

  October 23, 2018

   · 

  1 min read
• Drug Development

  Ocugen to Highlight Phase 2 Clinical Data for OCU310 at AAO 2018

  The poster will highlight the tolerability and preliminary efficacy results from a randomized Phase 2 proof-of-concept study in patients with DED.

  October 23, 2018

   · 

  2 min read
• FDA

  Correvio Announces Intention to Re-File Brinavess NDA in Second Quarter 2019

  Brinavess® is Correvio’s antiarrhythmic drug for the rapid conversion of recent onset atrial fibrillation (AF).

  October 23, 2018

   · 

  7 min read
• Pharm Country

  Immunomic Therapeutics CEO to Present at NYC Oncology Investor Conference

  To Discuss UNITE Technology Application in Oncology

  October 23, 2018

   · 

  2 min read